Skip to content

Omnilink Elite 1012632-19Recalls & reported problems

Abbott Vascular Inc. · Omnilink Elite Vascular Balloon-Expandable Stent System 9.0 mm x 19 mm x 135 cm Over-The-Wire · Class 3 · Implant

All models of Omnilink Elite (42)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
4
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 08717648178535), received between Mar 3, 2020 and Feb 29, 2024 — classified as 2 injuries, 2 malfunctions.

The most frequently reported specific device problem is “Device Dislodged or Dislocated” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 1 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Device Dislodged or Dislocated2
  • Migration2
  • Difficult or Delayed Activation1
  • Difficult to Advance1
  • Material Deformation1
  • Off-Label Use1

Patient problems

  • Foreign Body In Patient2
  • No Clinical Signs, Symptoms or Conditions1
  • No Patient Involvement1

Recent adverse event reports

The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.

  • InjuryFeb 29, 2024Off-Label Use; Migration; Off-Label Use; Migration

    IT WAS REPORTED THE PROCEDURE WAS TO TREAT A STENOSED LESION IN THE BRACHIOCEPHALIC ARTERY. AFTER THE LESION WAS PRE-DILATED WITH A NON-ABBOTT BALLOON CATHETER, THE 9.0X19MM OMNILINK ELITE STENT DELIVERY SYSTEM (SDS) WAS INFLATED TO 11 ATMOSPHERES (ATM) FOR 10 SECONDS. WHEN THE SDS WAS ATTEMPTED TO BE REMOVED, THE STENT MIGRATED PROXIMAL TO THE TARGET LESION. A NON-ABBOTT BALLOON CATHETER WAS USED TO OVER DILATE THE MIGRATED STENT TO COMPLETE THE PROCEDURE. THERE WAS NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE AND NO ADVERSE PATIENT SEQUELA. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: Foreign Body In Patient

    MAUDE report 18806185 ↗
  • MalfunctionJan 6, 2022Difficult to Advance; Device Dislodged or Dislocated; Material Deformation; Difficult to Advance; Device Dislodged or Dislocated; Material Deformation

    IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A MODERATELY CALCIFIED, MODERATELY TORTUOUS, 75% STENOSED LESION IN THE LEFT COMMON ILIAC ARTERY. A 9X19MM OMNI ELITE VASCULAR BALLOON EXPANDABLE STENT (BES) WAS ADVANCED TO THE TARGET LESION WITH RESISTANCE FROM THE ANATOMY. DEPLOYMENT WAS INITIATED AT THE TARGET LESION; HOWEVER, ONE OF THE STENT STRUTS WAS NOTED AS MANGLED AND DEPLOYMENT WAS ABORTED. THE DELIVERY SYSTEM AND PARTIALLY DEPLOYED STENT WAS REMOVED AS ONE UNIT WITHOUT ISSUE, AND ANOTHER OMNI ELITE BES WAS USED TO SUCCESSFULLY COMPLETE THE PROCEDURE. THERE WAS NO ADVERSE PATIENT EFFECT AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED. THE RETURNED DEVICE ANALYSIS FOUND THAT THE STENT WAS DISLODGED FROM THE BALLOON.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 13177094 ↗
  • InjuryAug 17, 2020Difficult or Delayed Activation; Migration; Difficult or Delayed Activation; Migration

    IT WAS REPORTED THE PROCEDURE WAS TO TREAT A TARGET LESION IN THE COMMON ILIAC ARTERY. WHEN DEPLOYING THE 9.0MMX19MMX135CM OMNILINK STENT IN THE TARGET LESION, THERE WAS LACK OF DISTAL DEPLOYMENT ON THE DISTAL EDGE OF THE STENT AND THE STENT MIGRATED INTO HEALTHY TISSUE IN THE EXTERNAL ILIAC ARTERY. THE DELIVERY SYSTEM WAS WITHDRAWN TO THE MIGRATED STENT AND THE STENT WAS IMPLANTED IN HEALTHY TISSUE AND FULLY APPOSED TO THE VESSEL WALL. A SECOND OMNILINK STENT WAS IMPLANTED WITHOUT ISSUE IN THE TARGET LESION. NO ADDITIONAL TREATMENT WAS PERFORMED. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: Foreign Body In Patient

    MAUDE report 10417705 ↗
  • MalfunctionMar 3, 2020Device Dislodged or Dislocated; Device Dislodged or Dislocated

    IT WAS REPORTED THAT DURING DEVICE PREPARATION OF THE OMNILINK ELITE STENT DELIVERY SYSTEM, AFTER REMOVAL FROM THE DISPENSER COIL AND REMOVAL OF THE PROTECTIVE SHEATH, WITHOUT RESISTANCE, IT WAS NOTED THAT THE STENT CAME OFF THE BALLOON. THE DEVICE WAS NOT USED AND THERE WAS NO PATIENT INVOLVEMENT. THERE WAS NO CLINICALLY SIGNIFICANT DELAY. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: No Patient Involvement

    MAUDE report 9782095 ↗

Other STENT, ILIAC devices

All STENT, ILIAC devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page